Soleus Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5M Sell
679,170
-527,685
-44% -$17.2M 0.91% 30
2025
Q4
$39.5M Sell
1,206,855
-519,698
-30% -$12.8M 1.46% 18
2025
Q3
$30.8M Buy
1,726,553
+267,158
+18% +$3.88M 1.55% 22
2025
Q2
$15.8M Buy
1,459,395
+13,278
+0.9% +$174K 1.05% 28
2025
Q1
$26.8M Sell
1,446,117
-1,509,826
-51% -$27.2M 1.93% 14
2024
Q4
$48.7M Sell
2,955,943
-50,000
-2% -$708K 3.06% 7
2024
Q3
$42.1M Sell
3,005,943
-299,872
-9% -$3.32M 3.26% 5
2024
Q2
$23.9M Buy
3,305,815
+200,000
+6% +$1.37M 2.11% 12
2024
Q1
$25.1M Buy
3,105,815
+510,000
+20% +$4.57M 1.86% 12
2023
Q4
$17.7M Sell
2,595,815
-1,190,014
-31% -$6.62M 1.97% 19
2023
Q3
$18.9M Buy
3,785,829
+1,995,831
+111% +$13.8M 1.75% 18
2023
Q2
$16.3M Buy
1,789,998
+10,000
+0.6% +$93.2K 1.82% 16
2023
Q1
$16.8M Buy
1,779,998
+1,024,000
+135% +$9.37M 1.74% 16
2022
Q4
$7.54M Buy
755,998
+331,000
+78% +$3.68M 1.08% 30
2022
Q3
$5.07M Buy
+424,998
New +$4.25M 0.69% 42
2021
Q4
Sell
-158,140
Closed -$2.5M 72
2021
Q3
$2.5M Hold
158,140
0.39% 58
2021
Q2
$3.42M Buy
+158,140
New +$3.2M 0.53% 38
2021
Q1
Sell
-33,813
Closed -$605K 74
2020
Q4
$605K Sell
33,813
-101,298
-75% -$1.49M 0.08% 61
2020
Q3
$1.57M Buy
135,111
+54,761
+68% +$636K 0.83% 38
2020
Q2
$742K Buy
80,350
+5,300
+7% +$47.5K 0.42% 47
2020
Q1
$781K Sell
75,050
-52,400
-41% -$667K 0.91% 26
2019
Q4
$2.28M Buy
+127,450
New +$1.88M 2.2% 16

Other funds holding AXGN

Soleus Capital Management's AXGN Position: Q1 2026 in Review

Soleus Capital Management reduced its Axogen (AXGN) stake by 44% in Q1 2026, selling an estimated $17.2M and leaving 679,170 shares worth $22.5M. The position accounts for 0.91% of the portfolio, ranked #30.

Soleus Capital Management first reported a position in AXGN in Q4 2019 and has held it in 22 quarters since. The position peaked at $48.7M in Q4 2024. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Soleus Capital Management held 679,170 shares of Axogen worth $22.5M as of Q1 2026.
  • Soleus Capital Management sold 527,685 Axogen shares in Q1 2026, an estimated $17.2M.
  • Axogen made up 0.91% of Soleus Capital Management's portfolio in Q1 2026, its #30 holding.
  • Soleus Capital Management first reported a position in Axogen in Q4 2019 and has held it in 22 quarters since.
  • Soleus Capital Management's Axogen position peaked at $48.7M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.